• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The Netrod™ six-electrode radiofrequency renal denervation system for uncontrolled hypertension: a sham-controlled trial.

作者信息

Li Yueping, Gao Fei, Ren Changjie, Ma Genshan, Bu Peili, Fu Guosheng, Chen Hao, Han Zhanying, Li Yan, Li Jing, Ma Xiang, Hao Liuyi, Chen Yundai, Chen Mao, Chen Xiaoping, Liu Xuebo, Jiang Jiangang, Yu Jing, Li Nanfang, Ma Xueping, Yang Bin, Cong Hongliang, Wang Xuekun, Fan Qingyong, Lv Shuzhi, Wu Dongliang, Dai Qiming, Qiu Fuyu, Cai Han, Zhou Yu-Jie

机构信息

Beijing Anzhen Hospital, Beijing, China.

Jining No. 1 People's Hospital, Jining, Shandong Province, China.

出版信息

Eur Heart J. 2024 Nov 21;45(44):4761-4764. doi: 10.1093/eurheartj/ehae703.

DOI:10.1093/eurheartj/ehae703
PMID:39431289
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11578641/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8851/11578641/a6079dae0076/ehae703f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8851/11578641/a6079dae0076/ehae703f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8851/11578641/a6079dae0076/ehae703f1.jpg

相似文献

1
The Netrod™ six-electrode radiofrequency renal denervation system for uncontrolled hypertension: a sham-controlled trial.用于治疗难治性高血压的Netrod™六电极射频肾去神经支配系统：一项假手术对照试验。
Eur Heart J. 2024 Nov 21;45(44):4761-4764. doi: 10.1093/eurheartj/ehae703.
2
Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial.在使用抗高血压药物的情况下肾动脉去神经术的长期疗效和安全性（SPYRAL HTN-ON MED）：一项随机、假手术对照试验。
Lancet. 2022 Apr 9;399(10333):1401-1410. doi: 10.1016/S0140-6736(22)00455-X. Epub 2022 Apr 4.
3
Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial.血管内超声肾去神经术治疗高血压（RADIANCE-HTN SOLO）：一项多中心、国际、单盲、随机、假对照试验。
Lancet. 2018 Jun 9;391(10137):2335-2345. doi: 10.1016/S0140-6736(18)31082-1. Epub 2018 May 23.
4
Efficacy and Safety of Catheter-Based Radiofrequency Renal Denervation in Chinese Patients With Uncontrolled Hypertension: The Randomized, Sham-Controlled, Multi-Center Iberis-HTN Trial.基于导管的射频肾去神经术治疗中国未控制高血压患者的疗效和安全性：随机、假对照、多中心 Iberis-HTN 试验。
Circulation. 2024 Nov 12;150(20):1588-1598. doi: 10.1161/CIRCULATIONAHA.124.069215. Epub 2024 Sep 4.
5
Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3.肾去神经术对 24 小时动态血压的影响：SYMPLICITY HTN-3 研究结果。
J Am Coll Cardiol. 2014 Sep 16;64(11):1071-8. doi: 10.1016/j.jacc.2014.05.012. Epub 2014 May 20.
6
Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial.基于导管的肾动脉去神经术治疗耐药性高血压的长期结果：随机 SYMPLICITY HTN-3 试验的最终随访。
Lancet. 2022 Oct 22;400(10361):1405-1416. doi: 10.1016/S0140-6736(22)01787-1. Epub 2022 Sep 18.
7
Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications.抗高血压药物治疗患者的肾脏去神经术的安全性和疗效。
J Am Coll Cardiol. 2023 Nov 7;82(19):1809-1823. doi: 10.1016/j.jacc.2023.08.045.
8
Effects of renal denervation on blood pressures in patients with hypertension: a systematic review and meta-analysis of randomized sham-controlled trials.肾去神经术对高血压患者血压的影响：随机假手术对照试验的系统评价和荟萃分析。
Hypertens Res. 2022 Feb;45(2):210-220. doi: 10.1038/s41440-021-00761-8. Epub 2021 Oct 17.
9
Catheter-based ultrasound renal denervation in patients with resistant hypertension: the randomized, controlled REQUIRE trial.基于导管的超声肾去神经术治疗耐药性高血压患者：随机、对照的 REQUIRE 试验。
Hypertens Res. 2022 Feb;45(2):221-231. doi: 10.1038/s41440-021-00754-7. Epub 2021 Oct 15.
10
Transurethral Renal Pelvic Denervation: A Feasibility Trial in Patients with Uncontrolled Hypertension.经尿道肾盂去神经术：在未控制的高血压患者中的可行性试验。
Hypertension. 2022 Dec;79(12):2787-2795. doi: 10.1161/HYPERTENSIONAHA.122.20048. Epub 2022 Oct 18.

引用本文的文献

1
Renal denervation for hypertension: cross-country cost-effectiveness insights from mainland China, Japan, and Thailand.肾去神经术治疗高血压：来自中国内地、日本和泰国的跨国成本效益分析见解
Health Econ Rev. 2025 Aug 13;15(1):69. doi: 10.1186/s13561-025-00669-w.
2
Evaluating cardioprotective strategies for anthracycline-induced cardiotoxicity in breast cancer: insights from a systematic review and network meta-analysis.评估乳腺癌中蒽环类药物所致心脏毒性的心脏保护策略：一项系统评价和网状Meta分析的见解
Cardiooncology. 2025 Jul 7;11(1):65. doi: 10.1186/s40959-025-00332-7.
3
Renal Denervation After USA FDA Approval: An Update from an Interventional Cardiologist's Perspective.

本文引用的文献

1
Endovascular Ultrasound Renal Denervation to Treat Hypertension: The RADIANCE II Randomized Clinical Trial.血管内超声肾脏去神经治疗高血压：RADIANCE II 随机临床试验。
JAMA. 2023 Feb 28;329(8):651-661. doi: 10.1001/jama.2023.0713.
2
Effect of Heart Rate on the Outcome of Renal Denervation in Patients With Uncontrolled Hypertension.心率对高血压未控制患者肾去神经治疗结局的影响。
J Am Coll Cardiol. 2021 Sep 7;78(10):1028-1038. doi: 10.1016/j.jacc.2021.06.044.
3
Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial.
美国食品药品监督管理局（FDA）批准后的肾去神经支配：介入心脏病专家视角的最新进展
J Clin Med. 2025 May 19;14(10):3554. doi: 10.3390/jcm14103554.
4
Renal Denervation: New Evidence Supporting Long-Term Efficacy, Alternative Access Routes, and Cost-Effectiveness.肾去神经支配：支持长期疗效、替代入路及成本效益的新证据
J Clin Hypertens (Greenwich). 2024 Dec;26(12):1528-1530. doi: 10.1111/jch.14945. Epub 2024 Nov 25.
超声肾动脉去神经术治疗三联药物治疗抵抗的高血压（RADIANCE-HTN TRIO）：一项随机、多中心、单盲、假手术对照试验。
Lancet. 2021 Jun 26;397(10293):2476-2486. doi: 10.1016/S0140-6736(21)00788-1. Epub 2021 May 16.
4
Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial.在不使用抗高血压药物的情况下基于导管的肾脏去神经术的疗效（SPYRAL HTN-OFF MED Pivotal）：一项多中心、随机、假对照试验。
Lancet. 2020 May 2;395(10234):1444-1451. doi: 10.1016/S0140-6736(20)30554-7. Epub 2020 Mar 29.
5
Measurement of Blood Pressure in Humans: A Scientific Statement From the American Heart Association.人类血压测量：美国心脏协会的科学声明。
Hypertension. 2019 May;73(5):e35-e66. doi: 10.1161/HYP.0000000000000087.
6
Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial.血管内超声肾去神经术治疗高血压（RADIANCE-HTN SOLO）：一项多中心、国际、单盲、随机、假对照试验。
Lancet. 2018 Jun 9;391(10137):2335-2345. doi: 10.1016/S0140-6736(18)31082-1. Epub 2018 May 23.
7
Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial.肾神经去交感神经术对降压药物治疗患者血压的影响：SPYRAL HTN-ON MED 概念验证随机试验的 6 个月疗效和安全性结果。
Lancet. 2018 Jun 9;391(10137):2346-2355. doi: 10.1016/S0140-6736(18)30951-6. Epub 2018 May 23.
8
Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial.在未使用抗高血压药物的情况下，基于导管的肾脏去神经术治疗未控制的高血压患者（SPYRAL HTN-OFF MED）：一项随机、假对照、概念验证试验。
Lancet. 2017 Nov 11;390(10108):2160-2170. doi: 10.1016/S0140-6736(17)32281-X. Epub 2017 Aug 28.
9
A controlled trial of renal denervation for resistant hypertension.经导管射频消融去肾交感神经术治疗高血压的对照试验
N Engl J Med. 2014 Apr 10;370(15):1393-401. doi: 10.1056/NEJMoa1402670. Epub 2014 Mar 29.
10
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.治疗抵抗性高血压患者的肾脏去神经支配（Symplicity HTN-2 试验）：一项随机对照试验。
Lancet. 2010 Dec 4;376(9756):1903-9. doi: 10.1016/S0140-6736(10)62039-9. Epub 2010 Nov 17.